Skip to ContentSkip to Navigation
How to find us drs. V.E.M. Mul


Addition of HER2 and CD44 to F-18-FDG PET-based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer

Locoregional Residual Esophageal Cancer after Neo-adjuvant Chemoradiotherapy and Surgery Regarding Anatomic Site and Radiation Target Fields: A Histopathologic Evaluation Study

Spleen Dose Influences Overall Survival In The Neo-Adjuvant Treatment Of Esophageal Cancer

The role of mindfulness and self-compassion in depressive symptoms and affect: A Comparison between Cancer Patients and Healthy Controls

A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy

Reasons for Low Uptake of a Psychological Intervention offered to Cancer Survivors with Elevated Depressive Symptoms

Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients

Site of residual oesophageal cancer after neo-adjuvant chemoradiotherapy with regard to the anatomical layers and radiation target volumes at histopathologic examination

Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging F-18-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study

Read more